Stock Update (NYSE:ACT): Actavis to Acquire Auden Mckenzie for 306M GBP

[PR Newswire] – DUBLIN and LONDON, Jan. 26, 2015 /PRNewswire/ — Actavis plc (ACT), a leading global specialty pharmaceutical company, and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing . . . → Read More: Stock Update (NYSE:ACT): Actavis to Acquire Auden Mckenzie for 306M GBP Similar Articles: Company Update: Actavis plc (NYSE:ACT) – Actavis Launches U.S. Generic Specialty Injectable Portfolio Stock Update (NYSE:ACT): Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference Market Update: Actavis plc (NYSE:ACT) – Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference